
ADMA Biologics Inc
NASDAQ:ADMA

Intrinsic Value
The intrinsic value of one
ADMA
stock under the Base Case scenario is
12.66
USD.
Compared to the current market price of 19.84 USD,
ADMA Biologics Inc
is
Overvalued by 36%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
ADMA Biologics Inc
Fundamental Analysis


Revenue & Expenses Breakdown
ADMA Biologics Inc
Balance Sheet Decomposition
ADMA Biologics Inc
Current Assets | 351.8m |
Cash & Short-Term Investments | 71.6m |
Receivables | 99.4m |
Other Current Assets | 180.8m |
Non-Current Assets | 158.8m |
PP&E | 65.7m |
Intangibles | 4m |
Other Non-Current Assets | 89m |
Free Cash Flow Analysis
ADMA Biologics Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
ADMA Biologics Inc
Revenue
|
459.4m
USD
|
Cost of Revenue
|
-217.8m
USD
|
Gross Profit
|
241.5m
USD
|
Operating Expenses
|
-90.7m
USD
|
Operating Income
|
150.8m
USD
|
Other Expenses
|
56m
USD
|
Net Income
|
206.8m
USD
|
ADMA Profitability Score
Profitability Due Diligence
ADMA Biologics Inc's profitability score is 54/100. The higher the profitability score, the more profitable the company is.

Score
ADMA Biologics Inc's profitability score is 54/100. The higher the profitability score, the more profitable the company is.
ADMA Solvency Score
Solvency Due Diligence
ADMA Biologics Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Score
ADMA Biologics Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ADMA Price Targets Summary
ADMA Biologics Inc
According to Wall Street analysts, the average 1-year price target for
ADMA
is 26.25 USD
with a low forecast of 21.17 USD and a high forecast of 33.6 USD.
Dividends
Current shareholder yield for ADMA is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
ADMA
stock under the Base Case scenario is
12.66
USD.
Compared to the current market price of 19.84 USD,
ADMA Biologics Inc
is
Overvalued by 36%.